Astri Astuti

Astri Astuti

Auto-generated profile, based on publicly available information

Astri Astuti

Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Padjadjaran - Bandung, West Java, Indonesia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Korean Circulation Journal
Verified
Journal Article
Open access
CNChoon Ta NG
Choon Ta NG
LTLi Ling Tan
Li Ling Tan
ISIl Suk Sohn
Il Suk Sohn
HBHilda Gonzalez Bonilla
Hilda Gonzalez Bonilla
TOToru Oka
Toru Oka
JHJoerg Herrmann
Joerg Herrmann
Korean Circulation Journal 대한심장학회지 순환기 Ng CT, et al. Korean Circ J. 2022 Nov;52:e109. https://doi.org/10.4070/kcj.2022.0255

18 September 2024 in ESC Heart Failure
Verified
Journal Article
Open access
HPHawani Sasmaya Prameswari
Hawani Sasmaya Prameswari
WKWilliam Kamarullah
William Kamarullah
RPRaymond Pranata
Raymond Pranata
IPIwan Cahyo Santosa Putra
Iwan Cahyo Santosa Putra
AUAlberta Claudia Undarsa
Alberta Claudia Undarsa
AAAstri Astuti
Astri Astuti
Aims: Peripartum cardiomyopathy (PPCM) may result in a number of detrimental adverse cardiovascular events, notably persistent left ventricular ejection fraction (LVEF) reduction or even mortality. Imaging parameters on cardiac magnetic resonance (CMR) and their prognostic implications have rarely been perused in PPCM. We aimed to describe CMR’s prognostic value in predicting poor left ventricular (LV) function recovery using late gadolinium enhancement (LGE) and T2-weighted or T2 mapping. Methods and results: PubMed, Europe PMC, and ScienceDirect were screened for studies on late gadolinium enhancement (LGE) and myocardial oedema using CMR and PPCM. The outcome of interest was poor LV function recovery, with a follow-up period of at least 6 months. Comparisons between groups with the presence of LGE, myocardial oedema, and recovered against non-recovered patients were pooled. A random-effects model was employed to calculate the effect size. All pooled results were expressed as risk ratios (RRs) and 95% confidence intervals (CI). The area under the curve (AUC) was generated to test overall prognostic accuracy. Six cohort studies with 162 patients were included. The mean age of participants in this study was 30.6 years, and the majority of patients were diagnosed with PPCM after delivery. LGE was associated with a higher risk of poor LV function recovery, particularly when conducted at a later stage of disease (≥2.8 months) [RR = 2.83 (95% CI = 1.25–6.40); P = 0.001]. On the contrary, CMR conducted early (<2.8 months) exhibited a greater predictive value for myocardial oedema perceived by T2 mapping [RR = 3.44 (95% CI = 1.04–11.34); P = 0.043]. Diagnostic-test accuracy meta-analysis revealed that LGE had a sensitivity of 73% (95% CI, 56–85%), specificity of 79% (95% CI, 45–95%), and AUC of 0.78 (95% CI, 0.75–0.82) in predicting poor LV recovery when performed in the later phase, whereas significant myocardial oedema in those with non-recovered LV function had a sensitivity of 12% (95% CI, 2–52%), specificity of 68% (95% CI, 39–88%), and AUC of 0.40 (95% CI, 0.36–0.44) while undertaken in the latter phase. Our findings support the notion that inflammation plays a significant role in PPCM and that alterations to tissue composition occur in a time-dependent manner. Conclusions: Contrast-enhanced CMR can be utilized as an adjunct examination in post-partum PPCM patients to stratify the risk of poor LV function recovery while conducted at a suitable point in time.

1 August 2021 in Cardiology Research
Verified
Journal Article
Open access
PDF file
AAAstri Astuti
Astri Astuti
EEErwinanto Erwinanto
Erwinanto Erwinanto
MAMuhammad Rizki Akbar
Muhammad Rizki Akbar
EMErwan Martanto
Erwan Martanto
DBDharmayanti Fransisca Badudu
Dharmayanti Fransisca Badudu
Global and Regional Longitudinal Strain Reduction in Breast Cancer Patients After First Chemotherapy Cycle With Fluorouracil, Adriamycin, and Cyclophosphamide Regimen

1 March 2024 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
HPHawani Sasmaya Prameswari
Hawani Sasmaya Prameswari
TDTriwedya Indra Dewi
Triwedya Indra Dewi
MHMelawati Hasan
Melawati Hasan
EMErwan Martanto
Erwan Martanto
AAAstri Astuti
Astri Astuti
CCCharlotte Johanna Cool
Charlotte Johanna Cool
Background: Due to the rarity of peripartum cardiomyopathy (PPCM) globally, baseline characteristic data for PPCM patients are still scarce. Therefore, this study aims to determine the baseline characteristics and 6-month outcomes of PPCM patients in Indonesia. Methods: From January 2014 to December 2021, all PPCM patients aged ≥ 18 years who were admitted to Dr. Hasan Sadikin General Hospital in Bandung, Indonesia, participated in this single-center, prospective cohort study. All patients were re-evaluated within 6 months of PPCM diagnosis. Results: A total of 138 patients with PPCM were admitted to Dr. Hasan Sadikin General Hospital in Bandung. The mean age of all patients was 30.4 ± 6.4 years old. Approximately 60% patients were multipara and had preeclampsia. All guideline-directed medical therapy for heart failure was received by most patients, excluding mineralocorticoid receptor antagonists (25.2%) and bromocriptine (14.1%). The neonatal mortality rate was 5.1%. Among those who survived, 61.2% had normal weight, 31.8% had low birth weight, and 7% had very low birth weight. At the 6-month follow-up, 6.7% of the patients died, 63.3% recovered, and 1.9% were rehospitalized. Conclusion: The present study found a high incidence of PPCM in Indonesia. Our patients frequently had preeclampsia, which contributed to the higher rate of miscarriage and low birth weight. Our liberal use of beta-blockers and ACEi/ARB may have contributed to the higher 6-month recovery rate than that in other countries.

1 August 2020 in IJC Heart & Vasculature
Verified
Journal Article
Open access
JMJanuar Wibawa Martha
Januar Wibawa Martha
DSDery A. Soedarsono
Dery A. Soedarsono
MIMohammad Iqbal
Mohammad Iqbal
AAAstri Astuti
Astri Astuti
EMErwan Martanto
Erwan Martanto
ISI. Gede Sumantra
I. Gede Sumantra
Despite its efficacy, FAC regimen may cause fatal cardiotoxicity. Carvedilol may also exert additional antioxidant effects. This study aimed to assess the effect of carvedilol in preventing decline of left ventricular function in breast cancer patients receiving FAC regimen chemotherapy. The study was a quasi-experimental study. The study subjects were consisted of breast cancer patients currently receiving post-first cycle FAC chemotherapy regimen in period of March – May 2019. The study subjects were divided into 2 groups: control and intervention group. In intervention groups, the patients consumed up titrated carvedilol with initial dose of 2 × 6.25 mg daily, follow-up echocardiography was performed for the patients in order to assess GLS score of left ventricle. Eighty patients were enrolled to the study, with each group consisted of 40 patients. Patient baseline characteristics were not significantly different between both groups. Left ventricular function was assessed using speckle tracking echocardiography and assessing the change of GLS score. Decrease of GLS score was higher in the intervention group compared to the control group, although the decrease was not statistically significant (0.767 ± 0.355 vs. 0.897 ± 0.526; p = 0.838). Percentage wise, similar findings were reported, albeit no significant (3.34 ± 1.65 vs. 3.46 vs. 2.58; p = 0.968). Carvedilol was not able to prevent the decline of subclinical left ventricular function after such chemotherapy cycle. However, it maybe more likely that the benefits appear in patients whose given larger cumulative dose of anthracycline and have multiple risk factors.

10 January 2025 in Indonesian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
FMFatihatul Firdaus Munita
Fatihatul Firdaus Munita
NKNuraini Yasmin Kusumawardhani
Nuraini Yasmin Kusumawardhani
CAChaerul Achmad
Chaerul Achmad
AAAstri Astuti
Astri Astuti
AMAzizah Muthiah
Azizah Muthiah
Background: The association between dyslipidemia and coronary artery disease (CAD) is undisputable. Current evidence suggests that, in comparison to conventional lipid parameters, a comprehensive non-traditional lipid profile serves as a more robust predictor of CAD. The evidence regarding the correlation between nontraditional lipid profile and severity of coronary lesions, as measured by the coronary artery disease-reporting and data system (CAD-RADS) score by Coronary Computed Tomography Angiography (CCTA), is still scarce. This study aimed to elaborate on the association between those parameters. Understanding these associations may improve risk stratification and management in CAD patients. Methods: A cross-sectional single-center study was conducted in a large population of patients with suspected CAD. Data were obtained from medical records between January 2020 and February 2024. The CAD-RADS score was stratified into three groups: CAD-RADS 0 (no CAD), CAD-RADS 1-2 (stenosis <50%, classified as non-obstructive CAD), and CAD-RADS ≥3 (stenosis ≥50% in ≥1 coronary segment, classified as obstructive CAD). Logistic regression analysis analyzes the association between patients' lipid profiles and CAD-RADS scores. P-value <0.05 was considered statistically significant. Results: A total of 543 (274 female) patients were included in this study. In the univariate analysis, the LDL/HDL ratio was significantly associated with the severity of CAD based on CAD-RADS scores. The multivariate analysis revealed that the LDL/HDL ratio was the most significant lipid parameter across all models (Adj OR: 9.728, 95% CI: 2.078-45.649, P = 0.004), with the highest adjusted odds ratio observed after adjustments for age, gender, family history, history of hypertension, diabetes mellitus, and chronic kidney disease, and also smoking status. The LDL/HDL ratio cut-off value was 2.82 with a sensitivity of 83.95% and a specificity of 21.05%. Other non-traditional lipid profiles lost their significance in the multivariate models. Conclusions: The LDL/HDL ratio was significantly associated with obstructive CAD, as assessed by the CAD-RADS score, even after adjustment for other cardiovascular risk factors